| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +4710.5% |
| Cost of Revenue | $209K | — |
| Gross Profit | $1.3M | +4044.1% |
| R&D Expense | $1.2M | +31.4% |
| SG&A Expense | $2.9M | -1.7% |
| Operating Income | -$3.5M | +23.0% |
| Net Income | -$3.8M | +16.4% |
| EPS (Basic) | -$0.10 | +41.2% |
| EPS (Diluted) | -$0.10 | +41.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $23K | +350.2% |
| Current Assets | $122K | -61.3% |
| Total Assets | $124K | -60.7% |
| Current Liabilities | $3.0M | +1.5% |
| Total Liabilities | $4.4M | +47.7% |
| Stockholders' Equity | -$4.3M | -60.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -16.4% |
| Capital Expenditures | $2K | — |
| Investing Cash Flow | -$2K | — |
| Financing Cash Flow | $2.8M | +66.7% |
| Free Cash Flow | -$3.0M | — |